Genetic variations in insulin signaling, such as the ENPP1 Lys121Gln and IRS1 Gly972Arg polymorphisms, are associated with NAFLD pathogenesis, adding complexity to the condition. Here, ENPP1 is linked to metabolic dysfunction-associated steatotic liver disease.